Skip to main content

Table 1 12 weeks EULAR Response FCGRIIA

From: Influence of variants of Fcg receptor IIA on the European league against rheumatism responses to anti-tumour necrosis factor alpha therapy in psoriatic arthritis

 

HH+HR

RR

Total

Null (%)

10.1

26.3

13.3

Moderate (%)

27.8

10.5

24.5

Good (%)

62.0

63.2

62.2

  1. p=0.086.